DB00816

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approval_status approved
gptkbp:ATCCode A10BA02
gptkbp:bioavailability 50-60%
gptkbp:brand gptkb:Riomet
gptkb:Fortamet
gptkb:Glucophage
gptkb:Glumetza
gptkbp:CASNumber 657-24-9
gptkbp:category antidiabetic agent
biguanide
hypoglycemic agent
gptkbp:color white
gptkbp:contraindication metabolic acidosis
renal impairment
gptkbp:discoveredBy gptkb:Jean_Sterne
gptkbp:discoveredIn 1957
gptkbp:drugClass biguanide
gptkbp:eliminationHalfLife 4-8.7 hours
gptkbp:excretion renal
gptkbp:first_marketed 1957
gptkbp:form C4H11N5
https://www.w3.org/2000/01/rdf-schema#label DB00816
gptkbp:indication gptkb:type_2_diabetes_mellitus
gptkbp:interactsWith gptkb:beer
cimetidine
contrast agents
gptkbp:legalStatus prescription only
gptkbp:maximum_daily_dose 2550 mg
gptkbp:mechanismOfAction decreases hepatic glucose production
increases insulin sensitivity
gptkbp:metabolism not metabolized
gptkbp:molecularWeight 129.164
gptkbp:name gptkb:Metformin
gptkbp:origin synthetic
gptkbp:patent_status off-patent
gptkbp:pregnancyCategory B
gptkbp:proteinBinding negligible
gptkbp:PubChem_CID gptkb:CHEMBL1431
gptkb:DB00816
gptkbp:riskFactor lactic acidosis
gptkbp:routeOfAdministration oral
gptkbp:sideEffect gastrointestinal upset
lactic acidosis
gptkbp:solubility freely soluble in water
gptkbp:synonym 1,1-dimethylbiguanide
dimethylbiguanide
gptkbp:tablet_strength 500 mg
1000 mg
850 mg
gptkbp:target gptkb:AMP-activated_protein_kinase
gptkb:mitochondrial_respiratory_chain_complex_I
gptkbp:UNII 9100L32L2N
gptkbp:WHOModelListOfEssentialMedicines yes
gptkbp:bfsParent gptkb:Fomepizole
gptkbp:bfsLayer 6